Warning! GuruFocus detected
1 Severe warning sign
with MAIA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
MAIA Biotechnology Inc
NAICS : 325412
SIC : 2834
ISIN : US5526411021
Description
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.36 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 1.7 | |||||
| 3-Year EPS without NRI Growth Rate | 2.2 | |||||
| 3-Year FCF Growth Rate | -22.1 | |||||
| 3-Year Book Growth Rate | -45.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 41.47 | |||||
| 9-Day RSI | 43.17 | |||||
| 14-Day RSI | 43.32 | |||||
| 3-1 Month Momentum % | -10.05 | |||||
| 6-1 Month Momentum % | -27.97 | |||||
| 12-1 Month Momentum % | -14.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.65 | |||||
| Quick Ratio | 2.65 | |||||
| Cash Ratio | 2.51 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -35 | |||||
| Shareholder Yield % | -39.13 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -3715.88 | |||||
| ROA % | -243.75 | |||||
| ROIC % | -1415.53 | |||||
| 3-Year ROIIC % | 4412.56 | |||||
| ROCE % | -432.13 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 11.65 | |||||
| Price-to-Tangible-Book | 11.57 | |||||
| EV-to-EBIT | -1.65 | |||||
| EV-to-Forward-EBIT | -1.49 | |||||
| EV-to-EBITDA | -1.65 | |||||
| EV-to-Forward-EBITDA | -1.48 | |||||
| EV-to-Forward-Revenue | 1.97 | |||||
| EV-to-FCF | -2.44 | |||||
| Price-to-Net-Current-Asset-Value | 11.57 | |||||
| Price-to-Net-Cash | 13.5 | |||||
| Earnings Yield (Greenblatt) % | -60.61 | |||||
| FCF Yield % | -32.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:MAIA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MAIA Biotechnology Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.09 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 107.1 | ||
| 14-Day RSI | 43.32 | ||
| 14-Day ATR ($) | 0.127426 | ||
| 20-Day SMA ($) | 1.6515 | ||
| 12-1 Month Momentum % | -14.55 | ||
| 52-Week Range ($) | 1.46 - 5.99 | ||
| Shares Outstanding (Mil) | 29.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
MAIA Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
MAIA Biotechnology Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
MAIA Biotechnology Inc Frequently Asked Questions
What is MAIA Biotechnology Inc(MAIA)'s stock price today?
The current price of MAIA is $1.62. The 52 week high of MAIA is $5.99 and 52 week low is $1.46.
When is next earnings date of MAIA Biotechnology Inc(MAIA)?
The next earnings date of MAIA Biotechnology Inc(MAIA) is 2025-05-30 Est..
Does MAIA Biotechnology Inc(MAIA) pay dividends? If so, how much?
MAIA Biotechnology Inc(MAIA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers